Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#108 most reported symptom for this vaccine
SARS-CoV-2 test positive has been reported 59 times in association with Influenza, Seasonal (Flucelvax Quadrivalent) vaccination in VAERS. This represents 0.7% of all 8,852 reports for this vaccine.
Among these reports, 1 mentioned death (1.69%) and 10 involved hospitalization (16.9%).
SARS-CoV-2 test positive is the #108 most frequently reported symptom for Influenza, Seasonal (Flucelvax Quadrivalent) out of 844 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 59 reports of SARS-CoV-2 test positive after Influenza, Seasonal (Flucelvax Quadrivalent) vaccination may seem alarming, but context is critical.
The mortality rate of 1.69% warrants monitoring, though VAERS deaths represent temporal associations, not confirmed causal links.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.